<DOC>
	<DOCNO>NCT00751738</DOCNO>
	<brief_summary>This open-label , multi-center , long-term , ( open-ended ) safety study 125 mg per day azimilide patient complete protocol 2000098 .</brief_summary>
	<brief_title>Long Term Safety 125 mg Per Day Oral Azimilide Patients With Implantable Cardioverter Defibrillator ( ICDs )</brief_title>
	<detailed_description />
	<mesh_term>Azimilide</mesh_term>
	<criteria>patient complete least 12 month study 2000098 inclusion study breast feeding plan become pregnant used ticlopidine take Class I Class III drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>